Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Inicio Conocimiento Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine

Rabbit Haemorrhagic Disease (RHD) prevention program based on the use of a European RHDV-2 vaccine


These two studies were aimed to evaluate the efficacy of ERAVAC® in naïve rabbits up to 6 months after immunization, although protection for a longer period of time (up to 12 month) as an aid to establish the most adequate prevention program for the disease was also explored.

Sobre este artículo

Apareció en

SVEPM Conference, 2018

Fecha

18 may. 2018

Autores

Sánchez-Matamoros, A.; Boix, O.; Ruiz, M. C.; Woodward, M.; Maldonado, J.

Resumen

This study demonstrates the following: • RHDV-2 vaccine stimulates the humoral response at 7 dpv, inducing high and long lasting antibody titers up to 12 mpv. • RHDV-2 vaccine confers protective immunity to virulent heterologous challenge. • A RHDV-2 prevention program could be based on a vaccination interval of at least 12 months.

Servicios relacionados

Productos relacionados

Compartir en